WHO Reassures Global Health Over Hantavirus Outbreak: Key Cases and Risks (Alternative concise options:) Hantavirus Outbreak: WHO Eases Concerns as Cases Emerge Globally Hantavirus Cases Reported After Cruise Ship Exposures – WHO’s Response

The World Health Organization (WHO) has reassured the global public that a recent hantavirus cluster linked to cruise ship travel poses a low risk to the broader population, while emphasizing ongoing monitoring and international coordination to contain the outbreak. As of May 13, 2026, the outbreak—confirmed as Andes virus (ANDV) infections—has resulted in 11 cases, including three deaths, with a case fatality ratio of 27%. The virus, which is the only known hantavirus capable of person-to-person transmission, has been detected among passengers of the Dutch-flagged cruise ship MV Hondius, with cases confirmed in France, Spain, the United Kingdom, and an inconclusive case under investigation in the United States.

The outbreak was first reported to the WHO on May 2, 2026, by the United Kingdom’s National IHR Focal Point, following the identification of severe respiratory illness among passengers. By May 8, eight cases had been confirmed, with three deaths recorded—a case fatality ratio of 38% at that time. Since then, additional cases have been reported, bringing the total to 11, including eight laboratory-confirmed ANDV infections, two probable cases, and one inconclusive result. The WHO’s risk assessment for the global population remains low, though the risk for passengers and crew on the affected ship is considered moderate.

Hantavirus infections are typically spread through contact with rodents, particularly through exposure to their urine, droppings, or saliva. The Andes virus is unique in its ability to transmit between humans, though such transmission is generally limited to close contact with an infected individual. Symptoms of hantavirus pulmonary syndrome (HPS), the most severe form caused by ANDV, include fatigue, fever, muscle aches, headaches, dizziness, and later-stage respiratory distress. Early symptoms may appear 1 to 8 weeks after exposure, with severe cases progressing to coughing and shortness of breath within days.

Public health authorities have activated the International Health Regulations (2005) to coordinate contact tracing and response efforts. National IHR Focal Points across affected countries are supporting these measures, while the WHO continues to assess the epidemiological situation. The organization has stated that it will update its risk assessment as new information emerges, though current data suggests no immediate threat to the general population beyond those directly exposed.

While the cruise ship cluster represents the first known instance of ANDV transmission outside its traditional geographic range in South America, health officials emphasize that the virus does not pose a widespread global risk. The WHO’s assessment aligns with earlier statements from the European Centre for Disease Prevention and Control (ECDC), which noted that the outbreak remains contained to a limited number of cases linked to the ship. However, the identification of the virus in regions where This proves not endemic—such as Europe and North America—highlights the importance of vigilance in travel-related health risks.

For travelers, health experts recommend standard precautions to avoid rodent exposure, including maintaining clean environments, sealing food storage, and avoiding contact with wild rodents. There is currently no vaccine or specific antiviral treatment for hantavirus infections, though supportive care can improve outcomes for those affected. The WHO has not issued travel advisories related to the cruise ship outbreak but advises passengers and crew to monitor for symptoms and seek medical attention if respiratory or flu-like illness develops.

As investigations continue, public health agencies are working to determine the source of the outbreak aboard the MV Hondius. Given the virus’s rarity outside South America, researchers are exploring whether the infection originated from an infected rodent onboard or through another transmission route. The WHO’s ongoing surveillance will be critical in assessing whether additional cases emerge or if the virus spreads beyond the ship’s passengers and crew.

For the general public, the outbreak serves as a reminder of the importance of global health surveillance and rapid response mechanisms. While the immediate risk remains low, the event underscores the need for continued monitoring of emerging infectious diseases, particularly those with zoonotic origins or the potential for human-to-human transmission.